4D MOLECULAR THERAPEUTICS IN's ticker is and the CUSIP is 35104E900. A total of 2 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -99.2% | 100 | -98.6% | 0.00% | – |
| Q2 2023 | $130 | -29.0% | 7,200 | -32.7% | 0.00% | – |
| Q1 2023 | $183 | +490.3% | 10,700 | +664.3% | 0.00% | – |
| Q4 2022 | $31 | -99.9% | 1,400 | -72.5% | 0.00% | – |
| Q3 2022 | $41,000 | -4.7% | 5,100 | -17.7% | 0.00% | – |
| Q2 2022 | $43,000 | -46.2% | 6,200 | +17.0% | 0.00% | – |
| Q1 2022 | $80,000 | – | 5,300 | +2550.0% | 0.00% | – |
| Q4 2021 | $0 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 100 | $1,273 | 0.00% |
| SIMPLEX TRADING, LLC | 100 | $1 | 0.00% |